Unknown

Dataset Information

0

SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53.


ABSTRACT: Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have demonstrated that squalene epoxidase (SQLE), as a key rate-limiting enzyme in cholesterol biosynthesis, is involved in cancer development. In this study, our analysis of The Cancer Genome Atlas, The Genotype-Tissue Expression, and Gene Expression Omnibus databases showed that SQLE expression was significantly higher in cancer tissues than it was in adjacent normal tissues, and BCa tissues with a high SQLE expression displayed a poor prognosis. We then confirmed this result in qRT-PCR and immunohistochemical staining experiments, and our vitro studies demonstrated that SQLE knockdown inhibited tumor cell proliferation and metastasis through the PTEN/AKT/GSK3β signaling pathway. By means of rescue experiments, we proved that that P53 is a key molecule in SQLE-mediated regulation of the PTEN/AKT/GSK3β signaling pathway. Simultaneously, we verified the above findings through a tumorigenesis experiment in nude mice. In conclusion, our study shows that SQLE promotes BCa growth through the P53/PTEN/AKT/GSK3β axis, which may serve as a therapeutic biological target for BCa.

SUBMITTER: Zou F 

PROVIDER: S-EPMC10540347 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53.

Zou Fan F   Chen Wu W   Song Tianbao T   Xing Ji J   Zhang Yunlong Y   Chen Kang K   Hu Weimin W   Li Linzhi L   Ning Jinzhuo J   Li Chenglong C   Yu Weimin W   Cheng Fan F  

Cancer cell international 20230928 1


Bladder cancer (BCa) is one of the most common malignancies worldwide. However, the lack of accurate and effective targeted drugs has become a major problem in current clinical treatment of BCa. Studies have demonstrated that squalene epoxidase (SQLE), as a key rate-limiting enzyme in cholesterol biosynthesis, is involved in cancer development. In this study, our analysis of The Cancer Genome Atlas, The Genotype-Tissue Expression, and Gene Expression Omnibus databases showed that SQLE expression  ...[more]

Similar Datasets

| S-EPMC2688529 | biostudies-literature
| S-EPMC11539788 | biostudies-literature
| S-EPMC10273921 | biostudies-literature
| S-EPMC5793418 | biostudies-literature
| S-EPMC11387860 | biostudies-literature
| S-EPMC8020055 | biostudies-literature
| S-EPMC6567415 | biostudies-literature
| S-EPMC9935627 | biostudies-literature
| S-EPMC8636648 | biostudies-literature
| S-EPMC9961967 | biostudies-literature